Nodify lung testing for lung nodules
Part of Cancer, Lungs & breathing clinical trials.
This study tests a blood test that helps doctors figure out if a lung nodule is likely to be cancer. The test may help avoid unnecessary procedures for people with suspicious but not clearly cancerous nodules.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 40 years or older.
- You have one or more lung nodules found on a CT scan, measuring between 4 and 30 millimeters.
- The nodule is solid or partly solid, not just a ground-glass opacity.
- Your doctor estimates the chance the nodule is cancer is 65% or less.
- You do not have a history of lung cancer or another active cancer needing treatment.
- You have not previously used the Nodify test or had the nodule biopsied or treated with radiation.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is collecting blood samples from people with lung nodules to help design a better test for lung cancer. It may help find cancer earlier without invasive procedures.
This study is testing a new method to help tell whether a lung nodule is benign (non-cancerous) or malignant (cancerous). It is for people who already need a biopsy or surgery for their lung nodule.
This trial uses a simple blood test to look at certain genetic markers that may help doctors decide if a lung nodule is cancerous or not. It is designed for people who have a lung nodule that needs further testing like a biopsy or surgery.
This study looks at lung nodules found on CT scans. Researchers will collect data from your breathing tests and CT scans to better understand how these nodules relate to lung cancer.
This study aims to see if a blood test can tell if a lung nodule is cancerous or not. It may help doctors avoid unnecessary procedures.
This study looks at whether a new test can better identify early lung cancer in people who are being watched for an incidental lung nodule. It may help doctors decide which nodules need closer follow-up or treatment.
Hear when a new Indeterminate Pulmonary Nodule trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.